Related Experiment Video
Updated: Sep 14, 2026

07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
Clinical use of recombinant human TSH in thyroid cancer patients
M Schlumberger1, M Ricard, F Pacini
1Department of Nuclear Medicine and Endocrine Tumors, Institut Gustave Roussy, 94805 Villejuif, Cèdex France. schlumbg@igr.fr
European Journal of Endocrinology
|November 18, 2000
Abstract:
Recombinant human TSH (rhTSH) is an effective and safe alternative to thyroid hormone withdrawal during the post-surgical follow-up of papillary and follicular thyroid cancer. Its clinical efficiency for the detection of persistent and recurrent disease is similar to that of thyroid hormone withdrawal. The main purpose for its use is to avoid hypothyroidism.

